For commercial partners and shareholders
Inhalation Drug DevelopmentExpert capabilitiesand enabling technologies
Oral Modified ReleaseA long track recordand validated technologies
Skyepharma’s success is built on partnering with life sciences companies. We are constantly seeking new collaboration opportunities to leverage our capabilities in the field of developing and delivering highly differentiated inhaled and oral products.
Our company invests in proprietary development programs which we typically seek to license out after clinical proof-of-concept. In parallel, we work with some of the most respected pharmaceutical companies to help them develop and commercialize their products using Skyepharma’s inhalation and oral technologies and related development capabilities.
With 16 products currently approved that were enabled by Skyepharma technologies, we bring a wealth of experience and know-how to support the product development and Life Cycle Management strategies of our partners. Our tailored services range from formulation development to scale-up, through clinical trial supplies and regulatory submissions to commercial manufacturing and supply chain management.
We welcome the opportunity to discuss the licensing of our products or technologies with you. Contact us if you are interested in discussing a potential collaboration with Skyepharma.
Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom
Tel: +44 207 881 0524
Fax: +44 207 881 1199
Tel: +41 61 467 5555
Fax: +41 61 467 5500